Skip to main content

Emerson M. Wickwire, PhD

Academic Title:


Primary Appointment:


Secondary Appointment(s):


Additional Title:

Section Head, Sleep Medicine


100 N. Greene St, 2nd Floor

Phone (Primary):


Phone (Secondary):




Education and Training

Certificate, Healthcare Leadership and Management, Johns Hopkins Carey Business School

Certificate, Business Matters for Scientists, Johns Hopkins Carey Business School

Fellowship, Behavioral Sleep Medicine, Johns Hopkins University School of Medicine

Residency, Psychology (concentration: sleep), The University of Mississippi Medical Center

PhD, Psychology, The University of Memphis

MS, Psychology, The University of Memphis

MA, English, Middlebury College

BA, English, Boston College



Section Head, Sleep Medicine

Dr. Emerson Wickwire is an internationally recognized expert in sleep and sleep disorders. He completed his advanced training in sleep at Johns Hopkins School of Medicine, where he also served as Assistant Professor. He previously co-founded a leading interdisciplinary sleep medicine center that became a model for comprehensive sleep medicine centers throughout the country. He is a frequently sought after expert and has been featured in publications including the Wall Street Journal, US News and World Report, Fast Company, the Baltimore Sun, and numerous others, and is regularly interviewed on local and national television.

Since returning to academia, Dr. Wickwire has developed a broad portfolio of sleep-related research that has been substantially funded by federal, foundation, and private industry partners. Since 2015 he has served as principal investigator on eleven extramural research grants as well as co-investigator on numerous other awards. One hundred percent of his project funders have become repeat funders for one or more additional follow-on studies.

Dr. Wickwire has published over 140 articles, including >100 peer-reviewed scientific articles, eight book chapters, and 25 articles for the professional audience on topics such as sleep health economics, sleep and cardiovascular and brain health, telehealth and telemedicine, home sleep apnea testing, sleep in the workplace, and patient communication skills. He serves on the Editorial Boards of Behavioral Sleep MedicineSLEEP, and Sleep Review and is Associate Editor of the Journal of Clinical Sleep Medicine. In 2017, he was awarded the Stuart Quan Award for Editorial Excellence "for displaying exemplary standard of excellence in work" as Associate Editor at JCSM.

Dr. Wickwire serves on the Board of Directors of the American Academy of Sleep Medicine (AASM) as well as the Sleep Medicine Advisory Committee of the American Board of Internal Medicine (ABIM). He is also an active and award-winning educator, having served on the education committees of the American Academy of Sleep Medicine, National Sleep Foundation, and American Pain Society. He holds a special interest in sleep in military populations and serves as a local site director for the Walter Reed National Army Medical Center/National Capitol Consortium sleep medicine fellowship. He is Past President of the Maryland Sleep Society.

An active speaker, Dr. Wickwire has presented invited lectures at Johns Hopkins School of Medicine, Memorial Sloan Kettering Cancer Center, NASA - Goddard, Children's National Medical Center, Georgetown University School of Medicine, Walter Reed Army Medical Center, Womack Army Medical Center at Fort Bragg, NC, the National Intrepid Center of Excellence at Bethesda Naval Medical Center, and elsewhere. His presentations on human motivation and behavior change were selected by his peers among the top 1% of over 1300 medical presentations in 2011.

Personally, Dr. Wickwire is deeply interested in literature, the arts, and the life of the mind. In addition to his scientific and applied endeavors, he is a past award recipient from the National Endowment of the Humanities, and he also spent two semesters studying literature at the University of Oxford, UK. His hard won insights into leadership, character, and personal responsibility were learned over two decades on the wrestling mats, as a former Academic All-American wrestler at NCAA Division I Boston College and successful high school wrestling coach. Today his greatest joys are spending time with his wife, son, and their English Springer Spaniel, Max.

Research/Clinical Keywords

Sleep, sleep medicine, sleep health economics, technology, telehealth

Highlighted Publications

Wickwire EM, Albrecht JS, Towe M, Abariga SA, Diaz-Abad M, Shipper AG, Cooper L, Assefa S, Tom SE, Scharf SM. The impact of treatments for obstructive sleep apnea on monetized health economic outcomes: a systematic review. Chest. 2019 Jan 18.

Wickwire EM, Tom SE, Scharf SM, Vadlamani A, Bulatao IG, Albrecht JS. Untreated Insomnia Increases All-Cause Health Care Utilization and Costs among Medicare Beneficiaries. Sleep. 2019 Jan 12.

Albrecht JS, Wickwire EM, Vadlamani A, Scharf SM, Tom SE. Trends in Insomnia Diagnosis and Treatment Among Medicare Beneficiaries, 2006–2013. The American Journal of Geriatric Psychiatry. 2018 Nov 2.

Wickwire EM, Schnyer DM, Germain A, Williams SG, Lettieri CJ, McKeon AB, Scharf SM, Stocker R, Albrecht JS, Badjatia N, Markowitz A, Manley GT. Sleep, sleep disorders, and circadian health following mild traumatic brain injury: Review and research agenda. J Neurotrauma.

Wickwire EM, Verma T. Value and Payment in Sleep Medicine. Journal of Clinical Sleep Medicine. 2018 May 15;14(05):881-4.34

Ohayon M, Wickwire EM, Hirshkowitz M, Albert SM, Avidan A, Daly FJ, Dauvilliers Y, Ferri R, Fung C, Gozal D, Hazen N, Krystal A, Lichstein K, Mallampalli M, Plazzi G, Rawding R, Scheer FA, Somers V, Vitiello MV. National Sleep Foundation's sleep quality recommendations: first report. Sleep Health. 2017 Feb;3(1):6-19.

Wickwire EM, Geiger-Brown J, Scharf SM, Drake CL. Shift work and Shift Work Sleep Disorder: Clinical and organizational perspectives. Chest. 2016 Dec 21. pii: S0012-3692(16)62598-9. doi: 10.1016/j.chest.2016.12.007. [Epub ahead of print] 

Wickwire EM. Value-based sleep in the workplace. Sleep. 2016 Oct 1;39(10):1767-1768. 

Wickwire EM, Williams SG, Roth T, Capaldi VF, Jaffe M, Moline M, Motamedi GK, Morgan GW, Mysliwiec V, Germain A, Pazdan RM, Ferziger R, Balkin TJ, MacDonald ME, Macek TA, Yochelson MR, Scharf SM, Lettieri CJ. Sleep, sleep disorders, and mild traumatic brain injury. What we know and what we need to know: Findings from a national working group. Neurotherapeutics. 2016 Mar 22:1-5.

Czeisler CA, Wickwire EM, Barger LK, Dement WC, Gamble K, Hartenbaum N, Ohayon MM, Pelayo R, Phillips B, Strohl K, Tefft B. Sleep-deprived motor vehicle operators are unfit to drive: a multidisciplinary expert consensus statement on drowsy driving. Sleep Health. 2016 Jun 30;2(2):94-9.

Tom SE, Wickwire EM, Park Y, Albrecht JS. Nonbenzodiazepine sedative hypnotics and risk of fall-related injury. Sleep. 2016 May 1;39(5):1009-14.

Wickwire EM, Shaya FA, Scharf SM. Health economics of insomnia treatments: The return on investment for a good night’s sleep. Sleep Med Rev. 2015 Nov 28;30:72-82.

Wickwire EM, Lettieri CJ, Cairns AA, Collop NA. Maximizing positive airway pressure adherence in adults: a common-sense approach. CHEST Journal. 2013 Aug 1;144(2):680-93.

Wickwire EM, Smith MT, Birnbaum S, Collop NA. Sleep maintenance insomnia complaints predict poor CPAP adherence: a clinical case series. Sleep medicine. 2010 Sep 30;11(8):772-6.

Wickwire EM, Collop NA. Insomnia and sleep-related breathing disorders. CHEST Journal. 2010 Jun 1;137(6):1449-63.

Wickwire EM, Schumacher JA, Clarke EJ. Patient‐reported benefits from the pre‐sleep routine approach to treating insomnia: Findings from a treatment development trial. Sleep and Biological Rhythms. 2009 Apr 1;7(2):71-7.

Clinical Specialty Details

Board-certified, Behavioral Sleep Medicine

Board-certified, Cognitive and Behavioral Psychology

Grants and Contracts




U.S. Department of Defense

Tele-Sleep OSA: Clinical effectiveness, implementation, and economic impact of telehealth care for obstructive sleep apnea in the military health system

Total costs (estimated): $5,465,905

Role: Principal Investigator



Merck & Co, Investigator-initiated Studies Program

The impact of suvorexant on cognitive function and daytime symptoms among older adults with insomnia: A randomized clinical trial using remote monitoring and ecological momentary assessment

Total costs: $496,483

Role: Principal Investigator



Sleep Research Society Foundation

Cardiovascular outcomes in patients with narcolepsy

Total costs: $400,000

Role: Co-I (PI: Kaufmann)



US Department of Defense

Value-based military sleep medicine: Health and economic aspects of sleep disorders treatments in the US military

Total costs: $2,000,000

Role: Principal investigator



ResMed Foundation (Investigator-initiated study)

Impact of untreated OSA on adverse depression outcomes among Medicare beneficiaries”

Total costs: $249,487

Role: Principal Investigator



National Institute of Aging

Sleep apnea treatment and risk for cognitive decline and Alzheimer’s disease

Total costs: $530,323 (UMB sub-contract) 

Role: Co-I (Site PI; Overall PI: Kaufmann)



National Institute of Aging

Recovery among older adults following head injury

Total costs: $3,875,807

Role: Co-Investigator (PI: Albrecht)



Merck & Co, Investigator-initiated Studies Program

The impact of insomnia on cognitive function and sleep variability among community-dwelling older adults with insomnia: A prospective study using remote monitoring and ecological momentary assessment

Total costs: $465,313

Role: Principal Investigator



U.S. Department of Defense (via Medical Technology Enterprise Consortium)

Integrated Tele-sleep mobile platform

Total costs: $2,000,000

Role: Principal Investigator






U.S. Department of Defense

Trajectories of insomnia and impact on recovery following traumatic brain injury

Total costs: $750,000

Role: Principal Investigator



AASM Foundation

Impact of High PAP Adherence on Cardiovascular Outcomes Among Medicare Beneficiaries with Obstructive Sleep Apnea, 2006-2015

Total costs: $249,691

Role: Co-Investigator (PI: Albrecht)



Merck & Co

Insomnia treatment among Medicare beneficiaries with Alzheimer's Disease

Total costs: $322,126*

Role: Principal Investigator

*Project cancelled due to budgetary changes within funder.



ResMed Corp   

Impact of untreated OSA and beneficial effect of PAP adherence on health care utilization among Medicare Beneficiaries with obstructive sleep apnea.

Total costs: $248,947

Role: Principal Investigator



AASM Foundation

Demonstrating the value of board certification in sleep medicine: Trends in diagnosis and impact on quality of care and economic outcomes among Medicare beneficiaries, 2006-2013

Total costs: $249,986

Role: Principal Investigator



Merck & Co (Investigator-initiated study)

Trends in insomnia diagnosis and treatment of insomnia and impact on healthcare utilization among older adult Medicare beneficiaries, 2006-2013.

Total costs: $256,455

Role: Principal Investigator


In the News